Spinal motoneurone distress during experimental allergic encephalomyelitis

Neuropathology and Applied Neurobiology

Volumn 30, Issue 5, 2004, Pages 522-531

  Giardino, L ^a,b   Giuliani, A ^a   Fernandez, M ^a   Calza L ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HESPERIA HOSPITAL   (Italy)

Author keywords

Demyelinating disease; Inflammation; Nerve growth factor; Neurone; Spinal cord

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CHOLINE ACETYLTRANSFERASE; FREUND ADJUVANT; MESSENGER RNA; NEUROTRANSMITTER; PROTEIN P75;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; CELL ACTIVATION; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; ENZYME SYNTHESIS; FEMALE; GENE CONTROL; GLIOSIS; GUINEA PIG; IMMUNIZATION; IN SITU HYBRIDIZATION; LUMBAR SPINAL CORD; MICROGLIA; MULTIPLE SCLEROSIS; MYCOBACTERIUM; NERVE CELL LESION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD MOTONEURON;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CHOLINE O-ACETYLTRANSFERASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION; GLIOSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE ACTIVATION; MICROGLIA; MOTOR NEURONS; RATS; RNA, MESSENGER; SPINAL CORD;

EID: 7044226614     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2004.00559.x     Document Type: Article

References (61)

1. Scolding NJ, Zajicek JP, Wood N, Compston DAS. The pathogenesis of demyelinating disease. Prog Neurobiol 1994; 43: 143-73
2. Merrill JE, Scolding NJ. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol Appl Neurobiol 1999; 25: 435-58
3. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000; 126: 1174-83
4. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9
5. Ganter P, Prince C, Esiri MM. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 1999; 25: 459-67
6. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001; 124: 1813-20
7. Bjartmar C, Yin X, Trapp BD. Axonal pathology in myelin disorders. J Neurocytol 1999; 28: 383-95
8. Rieckmann P, Smith KJ. Multiple sclerosis: more than inflammation and demyelination. Trends Neurosci 2001; 24: 435-7
9. Silber E, Sharief MK. Axonal degeneration in the pathogenesis of multiple sclerosis. J Neurol Sci 1999; 170: 11-8
10. Arnold DL. Magnetic resonance spectroscopy: imaging axonal damage in MS. J Neuroimmunol 1999; 98: 2-6
11. De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP, Arnold DL. In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 1999; 122: 1933-9
12. De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM, Arnold DL. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001; 58: 65-70
13. De Stefano N, Narayanan S, Matthews PM, Mortilla M, Dotti MT, Federico A, Arnold DL. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. J Neurovirol 2000; 2 (Suppl.): S121-9
14. Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, Barker GJ, Parker GJ, Thompson AJ, Miller DH. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001; 56: 926-33
15. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, Antel JP, Arnold DL. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121: 1469-77
16. Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, Arnold DL. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 1998; 18: 327-36
17. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000; 123: 1845-9
18. Kornek B, Storch MK, Bauer J, Djamshidian A, Weissert R, Wallstroem E, Stefferl A, Zimprich F, Olsson T, Linington C, Schmidbauer M, Lassmann H. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2001; 124: 1114-24
19. Dandekar AA, Wu GF, Pewe L, Perlman S. Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus. J Virol 2001; 75: 6115-20
20. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 2000; 157: 267-76
21. Onuki M, Ayers MM, Bernard CC, Orian JM. Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice. Microsc Res Tech 2001; 52: 731-9
22. Mancardi G, Hart B, Roccatagliata L, Brok H, Giunti D, Bontrop R, Massacesi L, Capello E, Uccelli A. Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J Neurol Sci 2001; 184: 41-9
23. Pouly S, Antel JP, Ladiwala U, Nalbantoglu J, Becher B. Mechanisms of tissue injury in multiple sclerosis: opportunities for neuroprotective therapy. J Neural Transm 2000; 58: 193-203
24. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat 1999; 194: 1-14
25. Calza L, Giardino L, Giuliani A, Aloe L, Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci USA 2001; 98: 4160-5
26. Giardino L, Giuliani A, Battaglia A, Carfagna N, Aloe L, Calzà L. Neuroprotection and aging of the cholinergic system: a role for the ergoline derivative nicergoline (Sermion). Neuroscience 2002; 109: 487-97
27. Hickey W, Gonatas NK, Kimura H, Wilson DB. Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J Immunol 1983; 131: 2805-9
28. Pozza M, Bettelli C, Aloe L, Giardino L, Calza L. Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution. Brain Res 2000; 855: 39-46
29. Dagerlind A, Friberg K, Bean AJ, Hokfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 1992; 98: 39-49
30. Calza L, Giardino L, Pozza M, Micera A, Aloe L. Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 1997; 94: 3368-73
31. Wu W. Potential roles of gene expression change in adult rat spinal motoneurons following axonal injury: a comparison among c-jun, off-affinity nerve growth factor receptor (LNGFR), and nitric oxide synthase (NOS). Exp Neurol 1996; 141: 190-200
32. Zhu B, Luo L, Moore GR, Paty DW, Cynader MS. Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis. Am J Pathol 2003; 162: 1639-50
33. Piehl F, Ji RR, Cullheim S, Hokfelt T, Lindholm D, Hughes RA. Fibroblast growth factors regulate calcitonin gene-related peptide mRNA expression in rat motoneurons after lesion and in culture. Eur J Neurosci 1995; 7: 1739-50
34. Krum JM, Rosenstein JM. Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds. Exp Neurol 1999; 160: 348-60
35. Arvidsson U, Piehl F, Johnson H, Ulfhake B, Cullheim S, Hokfelt T. The peptidergic motoneurone. Neuroreport 1993; 4: 849-56
36. Arvidsson U, Johnson H, Piehl F, Cullheim S, Hokfelt T, Risling M, Terenius L, Ulfhake B. Peripheral nerve section induces increased levels of calcitonin gene-related peptide (CGRP)-like immunoreactivity in axotomized motoneurons. Exp Brain Res 1990; 79: 212-6
37. Caldero J, Casanovas A, Sorribas A, Esquerda JE. Calcitonin gene-related peptide in rat spinal cord motoneurons: subcellular distribution and changes induced by axotomy. Neuroscience 1992; 48: 449-61
38. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000; 10: 381-91
39. Rende M, Hagg T, Manthorpe M, Varon S. Nerve growth factor receptor immunoreactivity in neurons of the normal adult rat spinal cord and its modulation after peripheral nerve lesions. J Comp Neurol 1992; 319: 285-98
40. Rende M, Provenzano C, Tonali P. Modulation of low-affinity nerve growth factor receptor in injured adult rat spinal cord motoneurons. J Comp Neurol 1993; 338: 560-74
41. Syroid DE, Maycox PJ, Soilu-Hanninen M, Petratos S, Bucci T, Burrola P, Murray S, Cheema S, Lee KF, Lemke G, Kilpatrick TJ. Induction of postnatal Schwann cell death by the low-affinity neurotrophin receptor in vitro and after axotomy. J Neurosci 2000; 20: 5741-7
42. Seeburger JL, Springer JE. Experimental rationale for the therapeutic use of neurotrophins in amyotrophic lateral sclerosis. Exp Neurol 1993; 124: 64-72
43. Bussmann KA, Sofroniew MV. Re-expression of p75NTR by adult motor neurons after axotomy is triggered by retrograde transport of a positive signal from axons regrowing through damaged or denervated peripheral nerve tissue. Neuroscience 1999; 91: 273-81
44. Povlishock JT. Traumatically induced axonal injury: pathogenesis and pathological implications. Brain Pathol 1992; 2: 1-12
45. Ransohoff RM, Trebst C. Surprising pleiotropy of nerve growth factor in the treatment of experimental autoimmune encephalomyelitis. J Exp Med 2000; 191: 1625-30
46. Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, Cheung SW, Mobley WC, Fisher S, Genain CP. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 2000; 191: 1799-806
47. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R. CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 2002; 8: 620-4
48. Levine JM, Reynolds R, Fawcett JW. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 2001; 24: 39-47
49. Barres BA, Raff MC. Control of oligodendrocyte number in the developing rat optic nerve. Neuron 1994; 12: 935-42
50. Demerens C, Stankoff B, Logak M, Anglade P, Allinquant B, Couraud F, Zalc B, Lubetzki C. Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci USA 1996; 93: 9887-92
51. Hardin-Pouzet H, Krakowski M, Bourbonniere L, Didier-Bazes M, Tran E, Owens T. Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis. Glia 1997; 20: 79-85
52. Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Linda H, van der Meide PH, Cullheim S, Olsson T, Piehl F. Neuroprotection by encephalomyelitis. Rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neuroscience 2000; 20: 5283-91
53. Sandyk R. Serotonergic neuronal sprouting as a potential mechanism of recovery in multiple sclerosis. Int J Neurosci 1999; 97: 131-8
54. Smith T, Groom A, Zhu B, Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nature Med 2000; 6: 62-6
55. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neuritis, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400
56. Meyer R, Weissert R, Diem R, Storch MK, de Graaf KL, Kramer B, Bahr M. Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci 2001; 21: 6214-20
57. Cid C, Alcazar A, Regidor I, Masjuaan J, Saunas M, Alvarez-Cermeno JC. Neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients correlates with hypointense lesions on T1 magnetic resonance imaging. J Neurol Sci 2002; 193: 103-9
58. Bjartmar C, Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 2001; 14: 271-8
59. Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125: 327-37
60. Simon JH. Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression. CNS Drugs 2001; 15: 427-36
61. Steinman L. Multiple approaches to multiple sclerosis. Nat Med 2000; 6: 15-6